Merck's Keytruda boosts response in hard-to-treat lung cancer


(Reuters) - The combination of Merck & Co's immunotherapy Keytruda and chemotherapy boosted response rates in patients with advanced hard-to-treat squamous cell lung cancer, the company said on Wednesday.


from Reuters: Health News https://ift.tt/2IuhDmQ
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Teen struggling w/ weight + no support at home, where the hell do I even start?

So I’m a teenager and I’ve been overweight/obese basically my whole life. And it’s been messing with me pretty bad. For the record, I don’...